159 related articles for article (PubMed ID: 18755695)
1. Natural D240G Toho-1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43.
Celenza G; Luzi C; Aschi M; Segatore B; Setacci D; Pellegrini C; Forcella C; Amicosante G; Perilli M
J Antimicrob Chemother; 2008 Nov; 62(5):991-7. PubMed ID: 18755695
[TBL] [Abstract][Full Text] [Related]
2. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
[TBL] [Abstract][Full Text] [Related]
3. A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop.
Bae IK; Lee BH; Hwang HY; Jeong SH; Hong SG; Chang CL; Kwak HS; Kim HJ; Youn H
J Antimicrob Chemother; 2006 Aug; 58(2):315-9. PubMed ID: 16785225
[TBL] [Abstract][Full Text] [Related]
4. Effect of D240G substitution in a novel ESBL CTX-M-27.
Bonnet R; Recule C; Baraduc R; Chanal C; Sirot D; De Champs C; Sirot J
J Antimicrob Chemother; 2003 Jul; 52(1):29-35. PubMed ID: 12775683
[TBL] [Abstract][Full Text] [Related]
5. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
Stürenburg E; Kühn A; Mack D; Laufs R
J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
[TBL] [Abstract][Full Text] [Related]
6. Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167.
Kimura S; Ishii Y; Tateda K; Yamaguchi K
Int J Antimicrob Agents; 2007 Mar; 29(3):326-31. PubMed ID: 17258896
[TBL] [Abstract][Full Text] [Related]
7. Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital.
Perilli M; Celenza G; Fiore M; Segatore B; Pellegrini C; Luzzaro F; Rossolini GM; Amicosante G
J Antimicrob Chemother; 2007 Oct; 60(4):877-80. PubMed ID: 17673478
[TBL] [Abstract][Full Text] [Related]
8. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and molecular characterization of 5 novel CTX-M enzymes carried by Klebsiella pneumoniae and Escherichia coli.
Cheng J; Ye Y; Wang YY; Li H; Li X; Li JB
Acta Pharmacol Sin; 2008 Feb; 29(2):217-25. PubMed ID: 18215351
[TBL] [Abstract][Full Text] [Related]
10. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9.
Delmas J; Robin F; Carvalho F; Mongaret C; Bonnet R
Antimicrob Agents Chemother; 2006 Feb; 50(2):731-8. PubMed ID: 16436733
[TBL] [Abstract][Full Text] [Related]
12. Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability.
Chen Y; Delmas J; Sirot J; Shoichet B; Bonnet R
J Mol Biol; 2005 Apr; 348(2):349-62. PubMed ID: 15811373
[TBL] [Abstract][Full Text] [Related]
13. Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Nagano Y; Nagano N; Wachino J; Ishikawa K; Arakawa Y
Antimicrob Agents Chemother; 2009 Jan; 53(1):69-74. PubMed ID: 18955524
[TBL] [Abstract][Full Text] [Related]
14. CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop.
Poirel L; Naas T; Le Thomas I; Karim A; Bingen E; Nordmann P
Antimicrob Agents Chemother; 2001 Dec; 45(12):3355-61. PubMed ID: 11709308
[TBL] [Abstract][Full Text] [Related]
15. Development of high-level ceftazidime resistance via single-base substitutions of blaCTX-M-3 in hyper-mutable Escherichia coli.
Karisik E; Ellington MJ; Pike R; Livermore DM; Woodford N
Clin Microbiol Infect; 2006 Aug; 12(8):803-6. PubMed ID: 16842579
[TBL] [Abstract][Full Text] [Related]
16. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.
Cartelle M; del Mar Tomas M; Molina F; Moure R; Villanueva R; Bou G
Antimicrob Agents Chemother; 2004 Jun; 48(6):2308-13. PubMed ID: 15155242
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterisation of the CTX-M-14 beta-lactamase.
Ishii Y; Galleni M; Ma L; Frère JM; Yamaguchi K
Int J Antimicrob Agents; 2007 Feb; 29(2):159-64. PubMed ID: 17207608
[TBL] [Abstract][Full Text] [Related]
18. Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases.
Delmas J; Chen Y; Prati F; Robin F; Shoichet BK; Bonnet R
J Mol Biol; 2008 Jan; 375(1):192-201. PubMed ID: 17999931
[TBL] [Abstract][Full Text] [Related]
19. Overexpression system and biochemical profile of CTX-M-3 extended-spectrum beta-lactamase expressed in Escherichia coli.
Perilli M; Ettorre D; Segatore B; Caporale B; De Santis F; Pochetti G; Brigante G; Mazza F; Tavìo MM; Amicosante G
FEMS Microbiol Lett; 2004 Dec; 241(2):229-32. PubMed ID: 15598537
[TBL] [Abstract][Full Text] [Related]
20. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
